Hypertension Clinical Trial
Official title:
A Randomized Controlled Trial to Evaluate the Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk
The chronic disease burden is increasing worldwide leading to a rise in the demand for
primary healthcare and a shortage of primary care physicians. Addressing this shortage
entails a multi-prong approach with innovations in care delivery, greater use of healthcare
technology, and more efficient use of all healthcare providers on the care team.
We previously developed an interactive self-service healthcare kiosk (Self-empowering and
enabling kiosk - SEEK® MyHealthKiosk) for the management of patients with stable chronic
disease in the primary care setting. A feasibility study using SEEK showed high levels of
acceptance and satisfaction from patients and healthcare providers.
The aim of this follow-up study is to evaluate the health outcomes of patients with stable
chronic disease who are on kiosk management compared to patients who are on routine
management by nurse clinicians. We hypothesize that patients who are managed by the kiosk
continue to maintain good disease control that are comparable to patients who are managed by
a nurse clinician.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | September 2019 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 75 Years |
Eligibility |
Inclusion Criteria: - are between the ages of 21 and 75 years - have at least one chronic medical condition that includes hypertension, hyperlipidemia, diabetes mellitus - have blood pressure, low-density lipoprotein cholesterol (LDL-C) and HbA1c levels within the recommended targets according to the Ministry of Health Singapore clinical practice guidelines for their current and last follow-up visits - are able to provide informed consent. Exclusion Criteria: - have serum creatinine more than 140 mmol/L (from tests done within the past year) - have serum potassium less than 3.5 mmol/L or more than 5 mmol/L (from tests done within the past year) - have overt proteinuria (urine protein:creatinine ratio more than 0.5) - were discharged from hospital or specialist follow-up within the last 6 months - have any pending laboratory or investigation result - are scheduled for any laboratory investigation within the next 4 months (except HbA1c or panel test) - have any new complaint related to their chronic medical conditions - have a known history of white coat hypertension |
Country | Name | City | State |
---|---|---|---|
Singapore | SingHealth Polyclinics - Punggol | Singapore |
Lead Sponsor | Collaborator |
---|---|
SingHealth Polyclinics | Agency for Science, Technology and Research |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disease control | 12 months | ||
Primary | Blood pressure | 12 months | ||
Primary | Low-density lipoprotein cholesterol | 12 months | ||
Primary | Hemoglobin A1c | 12 months | ||
Secondary | Visit duration | 8 months | ||
Secondary | Patient satisfaction questionnaire | The following areas of patient satisfaction will be scored on a Likert scale: convenience of visit schedule, location of kiosk or nurse consultation, appropriateness of management, duration of time spent in kiosk usage or nurse consultation, and the replacement of a doctor's visit by the kiosk or nurse clinician. Qualitative feedback will be captured via free-text inputs. | 12 months | |
Secondary | Adverse events | 12 months | ||
Secondary | Health-related quality of life questionnaire | Health-related quality of life will be assessed using the EQ-5D-5L questionnaire. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |